Type 2 diabetes: pharmacological intervention in an animal model.
Russell
J C
JC
Department of Surgery, Heritage Medical Research Centre, University of Alberta, Edmonton.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D001161:Arteriosclerosis / Q000235:genetics / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000235:genetics / Q000503:physiopathology; D004195:Disease Models, Animal; D005342:Fibrinolysis; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D011341:Probucol / Q000627:therapeutic use; D051381:Rats; D011922:Rats, Mutant Strains
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D007004:Hypoglycemic Agents; D011341:Probucol